Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Groupama Asset Managment

Groupama Asset Managment increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 27.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 66,706 shares of the medical equipment provider's stock after purchasing an additional 14,510 shares during the quarter. Groupama Asset Managment's holdings in Intuitive Surgical were worth $35,151,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical in the 4th quarter valued at $28,000. Summit Securities Group LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $30,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $31,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently commented on ISRG shares. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Evercore ISI increased their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. UBS Group raised their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Piper Sandler reaffirmed an "overweight" rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Finally, CICC Research assumed coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 target price on the stock. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $611.86.

Remove Ads

Intuitive Surgical Trading Down 8.7 %

NASDAQ ISRG traded down $43.21 during mid-day trading on Friday, reaching $451.40. 4,102,946 shares of the company's stock traded hands, compared to its average volume of 1,542,853. The company has a fifty day simple moving average of $547.83 and a 200-day simple moving average of $532.58. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market cap of $160.78 billion, a price-to-earnings ratio of 70.42, a P/E/G ratio of 5.85 and a beta of 1.55.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.